BM-131246
Modify Date: 2024-01-13 16:36:41
BM-131246 structure
|
Common Name | BM-131246 | ||
|---|---|---|---|---|
| CAS Number | 103787-97-9 | Molecular Weight | 408.47000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H20N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BM-131246BM-131246 is an oral antidiabetic agent. |
| Name | 5-{4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]benzyl}-2,4-thiazolidinedione |
|---|---|
| Synonym | More Synonyms |
| Description | BM-131246 is an oral antidiabetic agent. |
|---|---|
| Related Catalog | |
| In Vivo | BM-131246 is absorbed quickly and attains approximately proportional increase of the plasma levels in ob/ob mice. After repeated oral doses the terminal half-lives is about 4 h for BM-131246[1]. |
| References |
| Molecular Formula | C22H20N2O4S |
|---|---|
| Molecular Weight | 408.47000 |
| Exact Mass | 408.11400 |
| PSA | 106.73000 |
| LogP | 4.49440 |
| Storage condition | 2-8℃ |
| 5-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxyl]benzyl]thiazolidine-2,4-dione |
| 5-{4-[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione |
| AD-7057 |
| 5-(4-(2-(5-methyl-2-phenyloxazol-4-yl)-ethoxy)-benzyl)-thiazolidine-2,4-dione |
| BM-131246 |